SignalFDA/Bio

MONTE ROSA PLANS MID-STAGE TRIALS FOR ANTI-INFLAMMATORY AGENT AFTER POSITIVE PHASE 1 DATA - SEEKINGALPHA

Positive Phase 1 data prompts Monte Rosa mid-stage trials for anti-inflammatory agent.

What changed

Positive Phase 1 data prompts Monte Rosa mid-stage trials for anti-inflammatory agent.

Why it matters

Positive Phase 1 data prompts Monte Rosa mid-stage trials for anti-inflammatory agent. — impact context not separately stored; see What changed.

Sources